Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 9,318 in Johnson and Johnson

  1. High valuations put on older genericsRead the original story

    Sunday Jul 27 | The Telegraph

    Mumbai, July 27: GlaxoSmithKline Plc is likely to receive a good response if it indeed puts up its older but off-patented drugs for sale, given the massive gain Bafna Pharma made from Raricap.

    Comment?

  2. Generation Y's time has arrivedRead the original story w/Photo

    Saturday Jul 26 | The Times Leader

    In other words, get in the back seat of the car, baby boomers. You're no longer driving the American work force.

    Comment?

  3. Goldman close to settling FHFA suit on faulty mortgage claims, Bloomberg saysRead the original story

    Monday Jul 14 | Theflyonthewall.com

    On The Fly: Midday Wrap Stocks on Wall Street were lower at midday despite better than expected quarterly reports from two of the nation's largest financial institutions.

    Comment?

  4. Churning for Dollars - There Ought to Be a LawRead the original story

    Sunday Jul 27 | Common Dreams

    Remember Liz Fowler? She was the Wellpoint executive who took a brief sabbatical from her direct paychecks from the private health insurance industry to write the Affordable Care Act while working for Senator Max Baucus.

    Comment?

  5. 3 Stocks Senior Citizens Can Consider Purchasing Right NowRead the original story w/Photo

    Sunday Jul 27 | The Motley Fool

    Last week we took a closer look at some of the most common money mistakes that senior citizens make .

    Comment?

  6. Risperdal Meeting Scheduled for August in Pennsylvania Litigation, Bernstein Liebhard LLP ReportsRead the original story w/Photo

    Sunday Jul 27 | PRWeb

    The Firm is currently representing clients in Risperdal lawsuits that similarly allege the atypical antipsychotic medication caused gynecomastia, a condition categorized by male breast development.

    Comment?

  7. 2014 NHRA: Mopar Motorsports - NHRA Sonoma Nationals Fri PreviewRead the original story

    Saturday Jul 26 | Paddock Talk

    Following the mile-high challenge of altitude racing in the Rocky Mountains last week near Denver, the Mopar contingent is now back to running at sea-level amidst the vineyards of Northern California and ready to make a return to the winners circle at Sonoma Raceway for the 27th annual National Hot Rod Association Sonoma Nationals, the second stop ... (more)

    Comment?

  8. DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf...Read the original story w/Photo

    Saturday Jul 26 | PRWeb

    If you or someone you love were injured by a failing DePuy Pinnacle metal-on-metal hip replacement device, contact Wright & Schulte LLC for a free legal consultation at www.yourlegalhelp.com, or call 1-800-399-0795 Another DePuy Pinnacle hip lawsuit against Johnson & Johnson and its subsidiary, DePuy Orthopedics, Inc., has been filed by Wright & ... (more)

    Comment?

  9. First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge...Read the original story w/Photo

    Friday Jul 25 | PRWeb

    The Firm is representing numerous clients in this proceeding who were allegedly harmed by a metal-on-metal version of the Pinnacle Hip Replacement System.

    Comment?

  10. Weekly Market Wrap: July 25, 2014Read the original story

    Friday Jul 25 | Hispanic Business

    The thirtieth trading week of 2014 comes to a close with US markets lower in the last hour.

    Comment?

  11. Johnson & Johnson partners with Organovo to consider 3D-printing living tissueRead the original story w/Photo

    Thursday Jul 24 | GigaOM

    The partnership centers around using bioprinted tissue to discover new drugs. The announcement comes ahead of Organovo's commercial launch later this year.

    Comment?

  12. Puma's Auerbach Gained on Pfizer's Breast Drug RetreatRead the original story

    Friday Jul 25 | Bloomberg

    Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.

    Comment?

  13. CHMP's positive on Imbruvica for blood cancerRead the original story

    Friday Jul 25 | Seeking Alpha

    The EMA's Committee for Medicinal Products for Human Use adopt a positive opinion supporting approval of Imbruvica as a treatment for adult patients with relapsed or refractory mantle cell lymphoma or adult patients with chronic lymphocytic leukemia who have received at least one prior therapy or as a first-line treatment in patients with the 17p ... (more)

    Comment?

  14. Xarelto Side Effects Lawsuit News: New Lawsuit Alleges Xarelto...Read the original story w/Photo

    Friday Jul 25 | CNN

    Close to 10 Xarelto side effects lawsuits have been filed in the United States against Janssen Pharmaceuticals, a division of Johnson & Johnson and Germany-based Bayer AG over its blood-thinning medication.

    Comment?

  15. Europe backs new leukemia drugs from J&J and GileadRead the original story

    Friday Jul 25 | Reuters

    Two new leukemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

    Comment?

  16. Market Report, "Sun Care in Belgium (2014) - Market Sizes", PublishedRead the original story

    Friday Jul 25 | SBWire

    Sun Care in Belgium by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2014.

    Comment?

  17. Europe backs new leukaemia drugs from J&J and GileadRead the original story

    Friday Jul 25 | Reuters

    Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

    Comment?

  18. New Canton Church & Community Director on a mission to help othersRead the original story

    Thursday Jul 24 | Ogdensburg Courier-Observer/Journal

    Raymond E. Crosby has spent most of his career on the fast-track, selling medical equipment to healthcare faciltiies and training employees how to use the devices.

    Comment?

  19. Aaron's reports Q2 adjusted EPS 37c, consensus 35cRead the original story

    Friday Jul 11 | Theflyonthewall.com

    Aaron's sees Q3 adjusted EPS 36c-41c, consensus 46c Sees Q3 excluding franchisees revenue $695M, consensus $701.64M; Sees Q3 Progressive revenue $175M; Sees Q EBITDA for Progressive $15M-$17M On The Fly: Midday Wrap Stocks on Wall Street were lower at midday despite better than expected quarterly reports from two of the nation's largest financial ... (more)

    Comment?

  20. EMA recommends approval for Gilead, Janssen blood cancer drugsRead the original story

    Friday Jul 11 | Theflyonthewall.com

    Johnson & Johnson says innovation sustaining long-term growth Says MD&D progressing well towards 30 major filings by 2017.

    Comment?